导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 6.84% | 370/1050 |
| 近一周 | -0.61% | 379/1104 |
| 近一月 | -6.66% | 931/1103 |
| 近一季 | -18.38% | 937/1092 |
| 近半年 | 2.87% | 373/1070 |
| 近一年 | 9.45% | 383/1018 |
| 近两年 | 104.75% | 185/926 |
| 近三年 | 66.05% | 185/834 |
| 成立以来 | 96.22% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-1.64% 605/1070 |
38.86% 265/1101 |
- - |
- - |
| 2025 | 42.15% 293/1065 |
-0.01% 797/1014 |
2.19% 488/1038 |
40.17% 192/1050 |
-0.75% 485/1065 |
| 2024 | 13.87% 200/1011 |
-4.39% 550/960 |
-3.29% 531/983 |
23.30% 37/991 |
-0.13% 326/1011 |
| 2023 | -15.58% 549/952 |
1.90% 518/880 |
-6.13% 584/895 |
-7.97% 496/915 |
-4.10% 416/952 |
| 2022 | -28.88% 593/867 |
-16.26% 315/773 |
4.80% 528/806 |
-16.53% 651/845 |
-2.92% 572/867 |
| 2021 | 24.26% 122/740 |
-7.10% 421/580 |
37.43% 23/659 |
-2.42% 270/704 |
-0.26% 450/740 |
| 2020 | 60.22% 194/554 |
5.81% 64/419 |
29.23% 135/466 |
10.47% 241/517 |
6.07% 417/554 |
| 2019 | 34.02% 267/410 |
29.37% 407/1146 |
-6.32% 798/1228 |
3.28% 241/390 |
7.08% 273/410 |
| 2018 | - - |
- - |
-15.24% 769/990 |
-8.33% 671/1000 |
-7.65% 133/1080 |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票C | 0.8165 | 61.04% |
| 招商前沿医疗保健股票A | 0.8511 | 59.95% |
| 招商医药健康产业股票 | 2.6450 | 53.78% |
| 前海开源公共卫生股票A | 0.4748 | 42.37% |
| 嘉实医疗保健股票 | 2.6190 | 42.34% |
| 前海开源公共卫生股票C | 0.4647 | 42.24% |
| 广发医药精选股票A | 1.3315 | 41.03% |
| 广发医药精选股票C | 1.3103 | 40.86% |
| 交银医药创新股票C | 3.0948 | 37.26% |
| 交银医药创新股票A | 2.9144 | 36.05% |
| 光大创业板量化优选A VS. 东吴新产业精选股票A(580008) |